Home/Pipeline/XW10508

XW10508

Major Depressive Disorder and Chronic Pain

Phase 1Active

Key Facts

Indication
Major Depressive Disorder and Chronic Pain
Phase
Phase 1
Status
Active
Company

About XWPharma

Clinical-stage CNS biotech developing novel small molecules for narcolepsy, Parkinson's disease sleep disorders, depression, and chronic pain using time-regulated neurobiology.

View full company profile

Therapeutic Areas